and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the excess HBsAg present in circulating virions, large amounts of subviral particles containing HBsAg are ...

The isolated hepatitis B protein, produced by the yeast cells ... the subunit category is the anthrax vaccine approved in the U.S. (The countries of the former Soviet Union have an attenuated ...

Brii Biosciences has reported promising interim results from its Phase II ENSURE study of elebsiran, a hepatitis B ...

In animal studies, Dicerna’s drug cleared nearly 100% of circulating hepatitis B surface antigen (HBsAg), a protein that serves as a biomarker for infection. The hope is that keeping the virus ...

At least one-third of the world's population has been infected with ... the Australia antigen was shown to be the envelope protein of HBV. For many years, hepatitis B was recognized clinically ...

How it works: HBV can persist in liver cells ... a molecule directly to liver cells, where it's converted into an epigenetic-silencing protein that adds methyl groups to the viral DNA.